The Role
Support statistical activities for clinical trials, develop statistical analysis plans, collaborate with teams, and communicate results to stakeholders.
Summary Generated by Built In
SystImmune is a leading and well-funded clinical-stage biopharmaceutical company located in Redmond, WA and Princeton, NJ. It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs). SystImmune has multiple assets in various stages of clinical trials for solid tumor and hematologic indications. Alongside ongoing clinical trials. SystImmune has a robust preclinical pipeline of potential cancer therapeutics in the discover and IND-enabling stages, representing cutting-edge biologics development. We offer an opportunity for you to learn and grow while making significant contributions to the company's success.
We are seeking a Biostatistician to support clinical trial programs across Phase 1 through Phase 3 studies. This is an early-career role designed for candidates with a strong statistical foundation and initial industry experience who are looking to deepen their exposure to clinical development.
You will work closely with cross-functional teams, including clinical, regulatory, and international colleagues, to contribute to statistical analyses that inform decision-making across the clinical pipeline.
This position is full-time onsite and can be located in Redmond, WA; Sugarland, TX; or Princeton, NJ.
Key Responsibilities
Qualifications
Compensation and Benefits:
The expected base salary range for this position is $80,000 - $140,000 annually. Actual compensation will be based on a variety of factors, including but not limited to a candidate’s level qualifications, experience, and skills.
While most offers typically fall within the low to mid-point of the range, we may extend an offer toward the higher end for exceptional candidates whose background and expertise exceeds the requirements of the role.
SystImmune is a leading and well-funded biotech company with a bright future. We offer an opportunity for you to learn and grow while making significant contributions to the company’s success. SystImmune offers a comprehensive benefits package including: 100% paid employee premiums for medical/dental/vision, also STD, LTD, a 401(k) plan with a 50% company match of up to 3% and a vesting schedule of only 5 years, 15 PTO days per year, sick leave, plus 11 paid holidays and MORE.
We offer an opportunity for you to learn and grow while making significant contributions to the company’s success.
SystImmune is an Equal Opportunity Employer. We welcome diverse talent and encourage all qualified applicants to apply.
We are seeking a Biostatistician to support clinical trial programs across Phase 1 through Phase 3 studies. This is an early-career role designed for candidates with a strong statistical foundation and initial industry experience who are looking to deepen their exposure to clinical development.
You will work closely with cross-functional teams, including clinical, regulatory, and international colleagues, to contribute to statistical analyses that inform decision-making across the clinical pipeline.
This position is full-time onsite and can be located in Redmond, WA; Sugarland, TX; or Princeton, NJ.
Key Responsibilities
- Support statistical activities for clinical trials across Phase 1 to Phase 3 studies
- Develop statistical analysis plan
- Contribute to study design, including sample size estimation and statistical methodology
- Collaborate with clinical, data management, and programming teams to ensure data integrity and analysis accuracy
- Work with global teams, including close collaboration with colleagues in China
- Assist in interpretation of statistical results and communicate findings clearly to cross-functional stakeholders
Qualifications
- PhD in Biostatistics, Statistics, or a related quantitative field
- At least 1 year of industry experience in biostatistics within pharmaceutical, biotech, or CRO settings
- Hands-on experience supporting clinical trials (any phase)
- Proficiency in statistical programming (R and/or SAS)
- Understanding of clinical trial design, endpoints, and regulatory expectations
Compensation and Benefits:
The expected base salary range for this position is $80,000 - $140,000 annually. Actual compensation will be based on a variety of factors, including but not limited to a candidate’s level qualifications, experience, and skills.
While most offers typically fall within the low to mid-point of the range, we may extend an offer toward the higher end for exceptional candidates whose background and expertise exceeds the requirements of the role.
SystImmune is a leading and well-funded biotech company with a bright future. We offer an opportunity for you to learn and grow while making significant contributions to the company’s success. SystImmune offers a comprehensive benefits package including: 100% paid employee premiums for medical/dental/vision, also STD, LTD, a 401(k) plan with a 50% company match of up to 3% and a vesting schedule of only 5 years, 15 PTO days per year, sick leave, plus 11 paid holidays and MORE.
We offer an opportunity for you to learn and grow while making significant contributions to the company’s success.
SystImmune is an Equal Opportunity Employer. We welcome diverse talent and encourage all qualified applicants to apply.
Skills Required
- PhD in Biostatistics, Statistics, or a related quantitative field
- At least 1 year of industry experience in biostatistics
- Hands-on experience supporting clinical trials
- Proficiency in statistical programming (R and/or SAS)
- Understanding of clinical trial design and regulatory expectations
Am I A Good Fit?
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.
Success! Refresh the page to see how your skills align with this role.
The Company
What We Do
Located in Redmond WA, founded in 2014, Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and tri-specific antibodies, as well as antibody-drug conjugates (ADC's). Our objective is to create biologics that work through systematic intervention on the solid tumor micro-environment, to either directly attack the tumor and/or to activate the immune system to attack the tumor. We are a group of highly experienced immuno-oncology scientists utilizing several technology platforms to develop world class advanced antibody-based drug therapies.
